Insight Molecular Diagnostics is back in focus after analysts updated their price target, with some now pointing to US$12 alongside a refreshed fair value estimate of US$8.33, previously US$7.00. That ...

The system is intended for use in urgent care clinics, primary care settings, physician office laboratories, and pharmacies.

Opportunities in the North America molecular diagnostics market include rising demand due to increased chronic and infectious diseases, advances in point-of-care testing, and next-generation ...

Molecular diagnostics clarify hand dermatoses and guide targeted therapy in new research. Learn how gene-expression testing ...

The Companion Diagnostics Market has emerged as a critical pillar of modern precision medicine, enabling healthcare providers ...

When Domain Associates led Xagenic Inc.’s recent $20 million Series B, it marked the eighth diagnostics investment the firm had made with its $500 million eighth fund. The partners say they’ve ...

IMDX is trading in the middle of its 52-week range and above its 200-day simple moving average. Price change The price of IMDX shares has decreased $0.10 since the market last closed. This is a 1.74% ...

Global Molecular Infectious Disease Testing Market OverviewThe global molecular infectious disease testing market is ...

In the following sections, we highlight ethical concerns about early adoption of molecular diagnostic testing without solid evidence or guidelines and offer practical guidance for ethical ...

In recent times, investors have been increasingly drawn to companies operating in the molecular diagnostics space, a rapidly growing segment within the broader in-vitro diagnostics (IVD) market.

Molecular diagnostics market size to reach USD 38.01 billion by 2034: Polaris Market Research: United States Thursday, February 19, 2026, 09:00 Hrs [IST] The molecular diagnostics ...

The multi‑year renewal strengthens ABL’s integrated platform, improving revenue visibility and supporting the Group’s ...